EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

Biosafety level‐3 cryo‐electron tomography of active severe acute respiratory syndrome coronavirus 2 virions

Hideo Fukuhara iD, Hisham M Dokainish, Shunsuke Kita iD, Koshiro Tabata iD, Akira Takasu iD, Juha T Huiskonen iD, Yuki Anraku iD, Tomo Nomai iD, Taiyo Someya, Toshiya Senda iD, David I Stuart, Michihito Sasaki iD and 4 more

Protein Science · 2026-12 · 35 (12)

DOI: 10.1002/pro.70833 ↗

At a glance

Journal article in Protein Science, published online on 2026-11-05. Written by Hideo Fukuhara and 15 co-authors. Institution: Division of Pathogen Structure, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan. Major MEDLINE topics: Cryoelectron Microscopy, Electron Microscope Tomography, SARS-CoV-2, Virion. 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Japan Agency for Medical Research and Development, Global Institution for Collaborative Research and Education, Hokkaido University, Japan Science and Technology Agency.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Understanding the structural properties of pathogenic viruses in their native, infectious state is critical for rational vaccine and drug development. However, conducting cryo‐electron microscopy (cryo‐EM) under biosafety level 3 (BSL‐3) containment presents significant challenges. Here, we established and validated a high‐end cryo‐EM workflow within a BSL‐3 facility, comprehensively integrating facility design, containment measures, sample handling, cryo‐transfer systems, and decontamination protocols. To demonstrate the utility and reproducibility of this workflow, we applied cryo‐electron tomography to investigate severe acute respiratory syndrome coronavirus 2 in its native, active state. Our observations confirm that unfixed viral particles display pleomorphic features comparable to those previously reported in fixed or inactivated preparations, validating that these structural characteristics represent native features rather than artifacts of chemical fixation. Furthermore, spatial redistribution of surface spikes was observed. The establishment of this robust BSL‐3 cryo‐EM workflow provides a practical blueprint for the structural characterization of emerging high‐consequence pathogens, supporting pandemic preparedness, vaccine development, and antiviral discovery.

Subjects

MeSH terms (MEDLINE)

Cryoelectron MicroscopyElectron Microscope TomographySARS-CoV-2VirionContainment of BiohazardsAnimalsHumansCOVID-19

Author keywords

SARS‐CoV‐2cryo‐ETnative active virionsspike proteinvaccine design

Authors and institutions

  • Division of Pathogen Structure, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.
  • Laboratory of Biomolecular Science and Center for Research and Education on Drug Discovery, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
  • Global Station for Biosurfaces and Drug Discovery, Hokkaido University, Sapporo, Japan.
  • Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University, Sapporo, Japan.
  • Research Center for Vaccine Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
  • Division of Molecular Pathobiology, International Institute for Zoonosis Control, Hokkaido University, Sapporo, Japan.

ORCID profiles: Hideo Fukuhara, Shunsuke Kita, Koshiro Tabata, Akira Takasu, Juha T Huiskonen, Yuki Anraku, Tomo Nomai, Toshiya Senda, Michihito Sasaki, Yasuko Orba, Yasuhiko Suzuki, Hirofumi Sawa, Katsumi Maenaka

Funding

  • Japan Agency for Medical Research and Development
  • Global Institution for Collaborative Research and Education, Hokkaido University
  • Japan Science and Technology Agency
  • Japan Society for the Promotion of Science
  • Ministry of Health, Labour and Welfare
  • Takeda Science Foundation

Cite

APA

Fukuhara, H., Dokainish, H. M., Kita, S., Tabata, K., Takasu, A., Huiskonen, J. T., Anraku, Y., Nomai, T., Someya, T., Senda, T., Stuart, D. I., Sasaki, M., Orba, Y., Suzuki, Y., Sawa, H., & Maenaka, K. (2026). Biosafety level‐3 cryo‐electron tomography of active severe acute respiratory syndrome coronavirus 2 virions. Protein Science, 35(12). https://doi.org/10.1002/pro.70833

Vancouver

Fukuhara H, Dokainish HM, Kita S, Tabata K, Takasu A, Huiskonen JT, et al. Biosafety level‐3 cryo‐electron tomography of active severe acute respiratory syndrome coronavirus 2 virions. Protein Science. 2026;35(12). doi:10.1002/pro.70833

BibTeX
@article{Fukuhara2026,
  author = {Fukuhara, Hideo and Dokainish, Hisham M and Kita, Shunsuke and Tabata, Koshiro and Takasu, Akira and Huiskonen, Juha T and Anraku, Yuki and Nomai, Tomo and Someya, Taiyo and Senda, Toshiya and Stuart, David I and Sasaki, Michihito and Orba, Yasuko and Suzuki, Yasuhiko and Sawa, Hirofumi and Maenaka, Katsumi},
  title = {Biosafety level‐3 cryo‐electron tomography of active severe acute respiratory syndrome coronavirus 2 virions},
  journal = {Protein Science},
  year = {2026},
  volume = {35},
  number = {12},
  doi = {10.1002/pro.70833}
}
Start for free →